Cannabis
BevCanna Named Exclusive Canadian White Label Manufacturer of Marianna Naturals’ New CBD Wellness Beverage
Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE: BEV) (OTCQ: BVNNF) (FSE: 7BC) (“BevCanna” or the “Company”) announced today that it has entered into a non-binding letter of intent (the “LOI”) to manufacture white-label CBD wellness beverages for influential US health and beauty brand Marianna Naturals Corp. (“Marianna”).
Under the proposed definitive agreement contemplated in the LOI, BevCanna will become the exclusive Canadian manufacturing and distribution partner for Marianna’s new line of CBD-based wellness beverages. BevCanna will leverage its extensive experience in developing and launching beverages in the Canadian market to bring the popular brand to Canada, and will maintain responsibility and compliance with Health Canada. BevCanna will manufacture the beverage line through its pending standard processing license, and the subsequent receipt of its sales license.
Marianna will hold responsibility for national sales and marketing efforts to launch the product line in Canada. The white label agreement will be for an initial term of three years with a subsequent three-year renewal option.
“We’re very pleased to add a highly successful brand like Marianna to our growing portfolio of white-label partners,” said John Campbell, Chief Strategic Officer at BevCanna. “The proposed partnership fits well with our strategy of building out this vertical and our goal of achieving a consistent revenue stream for the business.”
“We’ve been looking for a partner that has the right combination of beverage manufacturing and regulatory expertise to bring our CBD beverage line to the Canadian market,” said Joel DeBellefeuille, Chief Executive Officer and Director of Marianna. “BevCanna fit the bill perfectly. We think that our customers will love the finished product.”
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE4 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth